Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA

Abstract Introduction Trimetazidine (TMZ) is an antianginal agent that acts directly at the myocardial cell level and which is now available in a once-daily (od) formulation. Methods ODA, a 3-month, observational, multicenter study in Russia, assessed the effectiveness and tolerability of TMZ 80 mg...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Maria G. Glezer, Vladimir A. Vygodin, ODA investigators
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Adis, Springer Healthcare 2020-05-01
Serie:	Cardiology and Therapy
Soggetti:	Chronic coronary syndrome Diagnosis duration Observational study Real-world evidence Stable angina Trimetazidine
Accesso online:	https://doi.org/10.1007/s40119-020-00174-7
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!